Pharmaceuticals

[New] The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Postmenopausal Osteoporosis Drugs market in 2020.
[New] Europe's artificial intelligence (AI) in drug discovery market reached $108.6 million in 2019 and will grow by 28.7% over 2020-2026, owing to the rising need for AI technology in drug discovery and development.
[New] Factors such as increasing demand for personalized drugs, increasing adoption of new technology in clinical research, growing research & development promoting outsourcing and increasing diseases prevalence will drive the RFID market in the forecast period of 2020 to 2027.
[New] The high cost of oral antidiabetic drugs is one of the major factors impeding the growth of the market over the forecast period of 2020-2027.
[New] The global anti-asthmatics and COPD drugs market is expected to grow from $40,162.1 million in 2019 to about $49,384.3 million in 2020 due to an increase in demand for the use of anti-asthmatics and COPD drugs in the treatment of Covid-19 patients.
[New] CMS's rules for ensuring that Medicaid receives the lowest price available for prescription drugs have not been updated in 30 years and are blocking the opportunity for markets to create innovative payment models.
[New] The North American artificial intelligence (AI) in drug discovery market is expected to grow by 29.5% annually in the forecast period and reach $894.1 million by 2026 despite the COVID-19 impact.
[New] The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Endometriosis Treatment Drugs market in 2020.
The pharmaceutical glass packaging market was valued at USD 15.6 billion in 2019 and is expected to reach USD 23.35 billion by 2025, at a CAGR of 6.5% over the forecast period 2020-2025.
The global artificial intelligence (AI) in the drug discovery market is expected to grow from $1.60 billion in 2019 to $40.36 billion by 2027.
The global Atorvastatin drug market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026.
Prescription weight loss drugs: Sales are forecast to decline 15% in 2020 in the U.S., to $590 million, as medical program caseloads at MD offices, clinics, and hospitals declined.
The global Artificial Intelligence (AI) in Drug Discovery Market size is estimated to reach USD 3,932.87 million by 2027, exhibiting a CAGR of 40.5% from 2020 to 2027.
The market payers from Liposome Drug Delivery Market are anticipated to lucrative growth opportunities in the future with the rising demand for Liposome Drug Delivery Market in the global market.
The market for injectables has been growing steadily over the last decade and projected growth is strong and being driven by the increasing number of drugs approved each year and the booming biologics space.
Russia will start administering its first approved antiviral drug to treat coronavirus patients next week, a move it described as a game changer that should speed a return to normal economic life.
The market is anticipated to record a CAGR of 3.8% over the forecast period, i.e. 2020-2027 and is further thriving on the back of rapid industrialization across the globe, rising demand for increasing crop yield in developing regions and increasing pharmaceutical applications of BTF.
Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks.
New drugs for breast cancer, lymphoma, multiple sclerosis and migraine are among new product launches this year that could top $1 billion in annual sales by 2024.
After the expiration of the patents of the two drugs Promacta and Nplate in the US (in 2022), in Europe in 2025 for Promacta, whereas, Nplate had already lost the patent rights last year, Doptelet is anticipated to emerge as the major product occupying Immune thrombocytopenia market share.
Network applications integrated with machine learning and 3D modeling methods will become an indispensable tool for computational drug discovery in the next years.
The head of the National Crime Agency has warned that criminals are likely to look to exploit opportunities during the coronavirus lockdown to import drugs and illegal migrants to the UK.

See full forecast

Last updated: 07 July 2020